Neural melanin sensitive MRI and methods of use thereof
A method for measuring the extent of one or more nervous system conditions, providing a diagnosis of one or more nervous system conditions, monitoring a treatment of one or more nervous system conditions, and monitoring a treatment of one or more nervous system conditions. Neural melanin sensitive magnetic resonance imaging ("MRI") techniques, methods, and computer accessible media to assess novel treatments for or determine prognosis associated with one or more nervous system disorders..
| Medienart: |
|
|---|
Patent| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Europäisches Patentamt - (2023) vom: 12. Sept. Zur Gesamtaufnahme - year:2023 |
|---|
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
CLARK SUZANNE [VerfasserIn] |
|---|
| Links: |
Volltext [kostenfrei] |
|---|
| Themen: |
Sonstige Themen: |
|---|
| Anmerkungen: |
Source: www.epo.org (no modifications made), First posted: 2023-09-12, Last update posted on www.tib.eu: 2023-12-12, Last updated: 2023-12-15 |
|---|
| Patentnummer: |
CN116745858 |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
EPA018739369 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | EPA018739369 | ||
| 003 | DE-627 | ||
| 005 | 20231215095237.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231215s2023 xx |||||o 00| ||eng c | ||
| 035 | |a (DE-627)EPA018739369 | ||
| 035 | |a (EPA)CN116745858 | ||
| 035 | |a (EPA)87904789 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 0 | |a CLARK SUZANNE |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Neural melanin sensitive MRI and methods of use thereof |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Source: www.epo.org (no modifications made), First posted: 2023-09-12, Last update posted on www.tib.eu: 2023-12-12, Last updated: 2023-12-15 | ||
| 520 | |a A method for measuring the extent of one or more nervous system conditions, providing a diagnosis of one or more nervous system conditions, monitoring a treatment of one or more nervous system conditions, and monitoring a treatment of one or more nervous system conditions. Neural melanin sensitive magnetic resonance imaging ("MRI") techniques, methods, and computer accessible media to assess novel treatments for or determine prognosis associated with one or more nervous system disorders. | ||
| 650 | 4 | |a G16H: Healthcare informatics, i.e. information and communication technology [ict] specially adapted for the handling or processing of medical or healthcare data | |
| 650 | 4 | |a rest | |
| 650 | 4 | |a 615 | |
| 700 | 0 | |a CASSIDY CATHAL |4 aut | |
| 700 | 0 | |a ROSA-NEDO PETER |4 aut | |
| 700 | 0 | |a WENGLER KERSTIN |4 aut | |
| 700 | 0 | |a HOLGAHERN ¨ ¢ NDEZ G ¨ ¢ BOR |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Europäisches Patentamt |g (2023) vom: 12. Sept. |
| 773 | 1 | 8 | |g year:2023 |g day:12 |g month:09 |
| 856 | 4 | 0 | |u https://worldwide.espacenet.com/patent/search/family/87904789/publication/CN116745858A1?q=CN116745858 |z kostenfrei |3 Volltext |
| 912 | |a GBV_EPA | ||
| 936 | u | w | |j 2023 |b 12 |c 09 |
| 951 | |a AR | ||
| 952 | |j 2023 |b 12 |c 09 | ||